NCT02249052View on ClinicalTrials.gov

Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2016

Conditions
Lipoma
Interventions
DRUG

AA4500

Subjects must present with 2 lipomas; one to receive AA4500 and one to receive placebo simultaneously

DRUG

placebo

Placebo

Trial Locations (2)

11557

Aesthetic Center, Hewlett

37232

Vanderbilt University, Nashville

All Listed Sponsors
collaborator

Advance Biofactures Corporation

INDUSTRY

lead

Gerut, Zachary, M.D.

INDIV

NCT02249052 - Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma | Biotech Hunter | Biotech Hunter